Botanical species · safety record

Saussurea costus

The EFSA Compendium of Botanicals holds 14 constituent measurements for Saussurea costus. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Saussurea costus (Falc.) Lipsch.

14Constituent measurements
0Safety records
2Cited sources
340Licensed products (Canada)

Also recorded as

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 340 licensed products naming Saussurea costus as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry
  • Extract Type TBA

Source material stated

  • Dried root(s)
  • Root
  • Volatile oil form dry root
  • root (roasted)

What the records describe

Constituents measured

  • Reynosin2
  • Santamarine2
  • Anthraquinones1
  • Chrysophanol1
  • Costunolide1
  • Cynaropicrin1
  • Dehydrocostus lactone1
  • Eleutheroside b1
  • Emodin1
  • Lignans1

Plant parts

  • Roots and other underground parts14

Preparations

  • Solvent extraction14

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
AnthraquinonesRoots and other underground partsSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
ChrysophanolRoots and other underground partsSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
CostunolideRoots and other underground partsSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
CynaropicrinRoots and other underground partsSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
Dehydrocostus lactoneRoots and other underground partsSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
Eleutheroside bRoots and other underground partsSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
EmodinRoots and other underground partsSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
LignansRoots and other underground partsSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
ReynosinRoots and other underground partsSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
ReynosinRoots and other underground partsSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
SantamarineRoots and other underground partsSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
SantamarineRoots and other underground partsSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
Sesquiterpene lactonesRoots and other underground partsSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
Sesquiterpene lactones type eudesmanolideRoots and other underground partsSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Li, S., An, TY., Li, J., Shen, Q., Lou, FC., Hu, LH. PTP1-B inhibitors from Saussrurea Lappa. Journal of asian natural products research, 2006, vol. 8, no. 3, p. 281-286. DOI
  2. Cho, JY., Park, JS., Yoo, ES., Baik, KU., Jung, JH., Lee, JS., Park, MH. Inhibitory effect of sesquiterpene lactones from Saussurea lappa on tumor necrosis factor-alpha production in murine macrophage-like cells . Planta medica, 1998, vol. 64, no. 7, p. 594-597. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue